Literature DB >> 24781193

Depletion of inflammatory dendritic cells with anti-CD209 conjugated to saporin toxin.

Michael N Alonso1, Josh G Gregorio, Matthew G Davidson, Joseph C Gonzalez, Edgar G Engleman.   

Abstract

Monocytes rapidly infiltrate inflamed tissues and differentiate into CD209(+) inflammatory dendritic cells (DCs) that promote robust immunity or, if unregulated, inflammatory disease. Previous studies in experimental animal models indicate that inflammatory DC depletion through systemic elimination of their monocyte precursors with clodronate-loaded liposomes ameliorates the development of psoriasis and other diseases. However, translation of systemic monocyte depletion strategies is difficult due to the importance of monocytes during homeostasis and infection clearance. Here, we describe a strategy that avoids the monocyte intermediates to deplete inflammatory DCs through antibody-loaded toxin. Mice with an abundance of inflammatory DCs as a consequence of lipopolysaccharide exposure were treated with anti-CD209 antibody conjugated to saporin, a potent ribosome inactivator. The results demonstrate depletion of CD209(+) DCs. This strategy could prove useful for the targeted reduction of inflammatory DCs in disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781193      PMCID: PMC4160227          DOI: 10.1007/s12026-014-8511-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  33 in total

1.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

2.  T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.

Authors:  Michael N Alonso; Michael T Wong; Angela L Zhang; Daniel Winer; Megan M Suhoski; Lorna L Tolentino; Juliana Gaitan; Matthew G Davidson; Tiffany H Kung; David M Galel; Kari C Nadeau; Jinah Kim; Paul J Utz; Kalle Söderström; Edgar G Engleman
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

3.  Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice.

Authors:  Ildiko R Dunay; Anja Fuchs; L David Sibley
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

4.  Th17 cells induce Th1-polarizing monocyte-derived dendritic cells.

Authors:  Matthew G Davidson; Michael N Alonso; Robert Yuan; Robert C Axtell; Justin A Kenkel; Megan M Suhoski; Joseph C González; Lawrence Steinman; Edgar G Engleman
Journal:  J Immunol       Date:  2013-06-21       Impact factor: 5.422

5.  An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.

Authors:  Moutih Rafei; Yamina A Berchiche; Elena Birman; Marie-Noëlle Boivin; Yoon Kow Young; Jian Hui Wu; Nikolaus Heveker; Jacques Galipeau
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

6.  Enhancement of saporin cytotoxicity by Gypsophila saponins--more than stimulation of endocytosis.

Authors:  A Weng; C Bachran; H Fuchs; E Krause; H Stephanowitz; M F Melzig
Journal:  Chem Biol Interact       Date:  2009-07-16       Impact factor: 5.192

Review 7.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells.

Authors:  Cedric Auffray; Michael H Sieweke; Frederic Geissmann
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.

Authors:  Cheolho Cheong; Ines Matos; Jae-Hoon Choi; Durga Bhavani Dandamudi; Elina Shrestha; M Paula Longhi; Kate L Jeffrey; Robert M Anthony; Courtney Kluger; Godwin Nchinda; Hyein Koh; Anthony Rodriguez; Juliana Idoyaga; Maggi Pack; Klara Velinzon; Chae Gyu Park; Ralph M Steinman
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

9.  Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Authors:  Esmeralda Juarez; Carlos Nuñez; Eduardo Sada; Jerrold J Ellner; Stephan K Schwander; Martha Torres
Journal:  Respir Res       Date:  2010-01-05

10.  In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells.

Authors:  Matthew G Davidson; Michael N Alonso; Justin A Kenkel; Megan M Suhoski; Joseph C González; Robert Yuan; Edgar G Engleman
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  4 in total

1.  Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

2.  Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.

Authors:  Mai M Abdelmoaty; Jatin Machhi; Pravin Yeapuri; Farah Shahjin; Vikas Kumar; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Clin Transl Med       Date:  2022-07

Review 3.  Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions).

Authors:  Maria Serena Fabbrini; Miku Katayama; Ikuhiko Nakase; Riccardo Vago
Journal:  Toxins (Basel)       Date:  2017-10-12       Impact factor: 4.546

4.  Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells.

Authors:  Lianne P W M Lelieveldt; Hendy Kristyanto; Ger J M Pruijn; Hans Ulrich Scherer; René E M Toes; Kimberly M Bonger
Journal:  Mol Pharm       Date:  2018-10-26       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.